Kymera Therapeutics, Inc.
KYMR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $113 | $336 | $90 | $120 |
| Short-Term Investments | $393 | $330 | $373 | $368 |
| Receivables | $0 | $40 | $20 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $23 | $23 | $18 | $21 |
| Total Curr. Assets | $528 | $728 | $501 | $510 |
| Property Plant & Equip (Net) | $88 | $95 | $96 | $98 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $479 | $303 | $312 | $362 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $5 | $9 | $8 |
| Total NC Assets | $574 | $403 | $417 | $468 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,102 | $1,131 | $918 | $978 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $10 | $6 |
| Short-Term Debt | $14 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $23 | $40 | $11 | $14 |
| Other Curr. Liab. | $17 | $21 | $1 | $0 |
| Total Curr. Liab. | $72 | $88 | $59 | $68 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $14 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $84 | $72 | $73 | $75 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $86 | $86 | $88 |
| Total Liabilities | $156 | $160 | $132 | $142 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$979 | -$897 | -$820 | -$755 |
| AOCI | $2 | $0 | -$0 | -$1 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $946 | $971 | $786 | $836 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,102 | $1,131 | $918 | $978 |
| Net Debt | -$99 | -$336 | -$90 | -$120 |